JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.5
Cite Score
SJR: 0.129 / SNIP: 0.140
Volume 17, Issue 2 (2025)
Iran J War Public Health 2025, 17(2): 191-196 |
Back to browse issues page
Article Type:
Subject:
Ethics code: INTI-FHLS-03-01-2021
History
Received: 2025/03/18 | Accepted: 2025/06/18 | Published: 2025/06/28
Received: 2025/03/18 | Accepted: 2025/06/18 | Published: 2025/06/28
How to cite this article
Alhnon F, Hassan F. Impact of Chemotherapy on Antioxidant Vitamins in Lymphoid Cancer. Iran J War Public Health 2025; 17 (2) :191-196
URL: http://ijwph.ir/article-1-1554-en.html
URL: http://ijwph.ir/article-1-1554-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
F.J.H. Alhnon *1, F.A. Hassan1
1- Department of Chemistry, College of Science, Al-Nahrain University, Baghdad, Iraq
Abstract (227 Views)
Aims: Lymphoid malignancies are increasingly prevalent in Iraq, where chemotherapy remains the principal treatment despite its association with oxidative stress. This study investigated the impact of chemotherapy on serum levels of antioxidant vitamins C, E, and D3 in patients with lymphoma.
Materials & Methods: This case-control study was conducted involving 120 individuals divided into three groups, including healthy controls (n=40), newly diagnosed untreated lymphoma patients (n=40), and lymphoma patients undergoing chemotherapy (n=40). Serum levels of vitamins C, E, and D3 were measured using ELISA, and statistical analysis was performed using ANOVA followed by Tukey’s post hoc analysis. The diagnostic potential was assessed through receiver operating characteristic curve analysis.
Findings: All lymphoma patients exhibited significantly reduced serum concentrations of vitamins C, E, and D3 compared to controls (p<0.0001). Chemotherapy-treated patients showed partial recovery in these levels, although the values remained below normal. Receiver operating characteristic analysis revealed strong discriminatory power for all three vitamins, especially vitamin D3, which emerged as a promising biomarker for disease presence and treatment monitoring.
Conclusion: Chemotherapy in lymphoma patients leads to partial improvement, but not normalization, of antioxidant vitamin levels.
Materials & Methods: This case-control study was conducted involving 120 individuals divided into three groups, including healthy controls (n=40), newly diagnosed untreated lymphoma patients (n=40), and lymphoma patients undergoing chemotherapy (n=40). Serum levels of vitamins C, E, and D3 were measured using ELISA, and statistical analysis was performed using ANOVA followed by Tukey’s post hoc analysis. The diagnostic potential was assessed through receiver operating characteristic curve analysis.
Findings: All lymphoma patients exhibited significantly reduced serum concentrations of vitamins C, E, and D3 compared to controls (p<0.0001). Chemotherapy-treated patients showed partial recovery in these levels, although the values remained below normal. Receiver operating characteristic analysis revealed strong discriminatory power for all three vitamins, especially vitamin D3, which emerged as a promising biomarker for disease presence and treatment monitoring.
Conclusion: Chemotherapy in lymphoma patients leads to partial improvement, but not normalization, of antioxidant vitamin levels.
Keywords:
References
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. [Link] [DOI:10.3322/caac.21660]
2. Jiang H, Zuo J, Li B, Chen R, Luo K, Xiang X, et al. Drug-induced oxidative stress in cancer treatments: Angel or devil?. Redox Biol. 2023;63:102754. [Link] [DOI:10.1016/j.redox.2023.102754]
3. Trehan S, Singh G, Singh A, Bector G, Jain A, Antil P, et al. Chemotherapy and metabolic syndrome: A comprehensive review of molecular pathways and clinical outcomes. Cureus. 2024;16(8):e66354. [Link] [DOI:10.7759/cureus.66354]
4. Chandimali N, Bak SG, Park EH, Lim HJ, Won YS, Kim EK, et al. Free radicals and their impact on health and antioxidant defenses: A review. Cell Death Discov. 2025;11:19. [Link] [DOI:10.1038/s41420-024-02278-8]
5. Carlberg C. Nutrigenomics of Vitamin D. Nutrients. 2019;11(3):676. [Link] [DOI:10.3390/nu11030676]
6. Shen HR, Tang J, Li WY, Liang JH, Li Y, Wu JZ, et al. 25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas. Ann Hematol. 2024;103(2):565-74. [Link] [DOI:10.1007/s00277-023-05536-4]
7. Borchmann S, Cirillo M, Goergen H, Meder L, Sasse S, Kreissl S, et al. Pretreatment Vitamin D deficiency is associated with impaired progression-free and overall survival in Hodgkin lymphoma. J Clin Oncol. 2019;37(36):3528-37. [Link] [DOI:10.1200/JCO.19.00985]
8. Caruso F, Pedersen JZ, Incerpi S, Belli S, Sakib R, Rossi M. Interaction between Vitamins C and E when scavenging the superoxide radical shown by hydrodynamic voltammetry and DFT. Biophysica. 2024;4(2):310-26. [Link] [DOI:10.3390/biophysica4020022]
9. Grinan-Lison C, Blaya-Canovas JL, Lopez-Tejada A, Avalos-Moreno M, Navarro-Ocon A, Cara FE, Gonzalez-Gonzalez A, Lorente JA, Marchal JA, Granados-Principal S. Antioxidants for the treatment of breast cancer: Are we there yet?. Antioxidants. 2021;10(2):205. [Link] [DOI:10.3390/antiox10020205]
10. Bodeker KL, Smith BJ, Berg DJ, Chandrasekharan C, Sharif S, Fei N, et al. A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. Redox Biol. 2024;77:103375. [Link] [DOI:10.1016/j.redox.2024.103375]
11. Dong R, Wang J, Guan R, Sun J, Jin P, Shen J. Role of oxidative stress in the occurrence, development, and treatment of breast cancer. Antioxidants. 2025;14(1):104. [Link] [DOI:10.3390/antiox14010104]
12. Li C, Zhu Z, Jiang S, Feng X, Yang L, Gao K, et al. The relationship between serum vitamin C levels and high-sensitivity C-reactive protein in children. Sci Rep. 2024;14(1):31734. [Link] [DOI:10.1038/s41598-024-81751-x]
13. Lewis ED, Meydani SN, Wu D. Regulatory role of vitamin E in the immune system and inflammation. IUBMB Life. 2019;71(4):487-94. [Link] [DOI:10.1002/iub.1976]
14. Murdaca G, Tonacci A, Negrini S, Greco M, Borro M, Puppo F, et al. Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications. Autoimmun Rev. 2019;18(9):102350. [Link] [DOI:10.1016/j.autrev.2019.102350]
15. Chiang FF, Huang SC, Yu PT, Chao TH, Huang YC. Oxidative stress induced by chemotherapy: Evaluation of glutathione and its related antioxidant enzyme dynamics in patients with colorectal cancer. Nutrients. 2023;15(24):5104. [Link] [DOI:10.3390/nu15245104]
16. Ping L, Gao Y, He Y, Wang X, Bai B, Huang C, et al. Systematic oxidative stress indexes associated with the prognosis in patients with T Lymphoblastic Lymphoma/Leukemia. Oxid Med Cell Longev. 2022;2022:2679154. [Link] [DOI:10.1155/2022/2679154]
17. Sluyter JD, Manson JE, Scragg R. Vitamin D and clinical cancer outcomes: A review of meta-analyses. JBMR Plus. 2020;5(1):e10420. [Link] [DOI:10.1002/jbm4.10420]
18. Li L, Zhang L, Tian Y, Zhang T, Duan G, Liu Y, et al. Serum chemokine CXCL7 as a diagnostic biomarker for colorectal cancer. Front Oncol. 2019;9:921. [Link] [DOI:10.3389/fonc.2019.00921]
19. Selvaraj NR, Nandan D, Nair BG, Nair VA, Venugopal P, Aradhya R. Oxidative stress and redox imbalance: Common mechanisms in cancer stem cells and neurodegenerative diseases. Cells. 2025;14(7):511. [Link] [DOI:10.3390/cells14070511]
20. Shakir N. Evaluating the level of some antioxidants and C-reactive activators protein in a sample of Iraqi women with breast cancer. Iraqi J Cancer Med Genet. 2024;17(1):51-6. [Link] [DOI:10.29409/ijcmg.v17i1.349]